The CKD Patient with Dyslipidemia

The prevalence of chronic kidney disease (CKD) is increasing alarmingly, mainly as a result of an ongoing epidemic of obesity, metabolic syndrome, and diabetes mellitus. CKD is a notorious risk multiplier for development of cardiovascular disease, which, itself, is well known to be the leading cause of morbidity and mortality in patients with CKD. Cardiovascular morbidity and mortality are significantly increased along the continuum of CKD, reaching a tenfold higher risk in end-stage renal disease population when compared to general population.